HQY Relative Valuation
HQY's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, HQY is overvalued; if below, it's undervalued.
Historical Valuation
Healthequity Inc (HQY) is now in the Undervalued zone, suggesting that its current forward PE ratio of 25.25 is considered Undervalued compared with the five-year average of 36.47. The fair price of Healthequity Inc (HQY) is between 100.95 to 174.41 according to relative valuation methord. Compared to the current price of 100.12 USD , Healthequity Inc is Undervalued By 0.82%.
Relative Value
Fair Zone
100.95-174.41
Current Price：100.12
0.82%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
3.99
P/B
Median3y
3.25
Median5y
3.24
3.90
FCF Yield
Median3y
3.47
Median5y
3.18
Competitors Valuation Multiple
The average P/S ratio for HQY's competitors is 6.65, providing a benchmark for relative valuation. Healthequity Inc Corp (HQY) exhibits a P/S ratio of 6.52, which is -2.00% above the industry average. Given its robust revenue growth of 15.04%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is Healthequity Inc (HQY) currently overvalued or undervalued?
What is Healthequity Inc (HQY) fair value?
How does HQY's valuation metrics compare to the industry average?
What is the current P/B ratio for Healthequity Inc (HQY) as of Jul 19 2025?
What is the current FCF Yield for Healthequity Inc (HQY) as of Jul 19 2025?
What is the current Forward P/E ratio for Healthequity Inc (HQY) as of Jul 19 2025?